-->

Dr. Jin-hong Park Radiation Oncology


Consultant - Radiation Oncologist , Experience:

Book Appointment

About Doctor

Dr. Jin-hong Park is among the top radiation oncologist in Seoul, South Korea.

Dr. Jin-hong Park education
  • Doctor of Medicine : University of Ulsan
  • Master of Medicine : University of Ulsan
  • Bachelor of Medicine : Chonbuk National University
Dr. Jin-hong Park professional experiences
  • Assist Professor in Radiation Oncology, UUCM AMC
  • Fellowship in Radiation Oncology, UUCM AMC
  • Public Health Doctor
  • Residency in Radiation Oncology, UUCM AMC
  • Internship in UUCM AMC

Hospital

Asan Medical Centre, Seoul, South Korea

Specialization

  • Cyber Knife,
  • Rectal & Gastrointestinal Cancer,
  • Palliative Radiotherapy,
  • Brain Tumor
  • Esophageal cancer

Procedures Performed

  • Cyber knife treatment
  • Rectal cancer radiotherapy
  • Brain tumor radiotherapy
  • Esophageal cancer radiotherapy

Research & Publications

Evaluation of delivered dose to a moving target by 4D dose reconstruction in gated volumetric modulated arc therapy
Stereotactic body radiation therapy using a respiratory-gated volumetric-modulated arc therapy technique for small hepatocellular carcinoma
Efficacy and safety of neoadjuvant FOLFIRINOX for borderline resectable pancreatic adenocarcinoma: improved efficacy compared with gemcitabine-based regimen
Efficacy and safety of ultrasound-guided implantation of fiducial markers in the liver for stereotactic body radiation therapy.
Impact of a Multidisciplinary Team Approach for Managing Advanced and Recurrent Colorectal Cancer.
Local Control Outcomes Using Stereotactic Body Radiation Therapy for Liver Metastases From Colorectal Cancer.
Postoperative Radiotherapy for Pancreatic Cancer with Microscopically-positive Resection Margin.
Prognosis of Pancreatic Cancer Patients with Synchronous or Metachronous Malignancies from Other Organs Is Better than Those with Pancreatic Cancer Only.
Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin: retrospective analysis of 740 patients.
Refining prognostic stratification of human papillomavirus-related oropharyngeal squamous cell carcinoma: different prognosis between T1 and T2.
Role of fractionated radiotherapy in patients with hemangioma of the cavernous sinus.
Total Mesorectal Excision Versus Local Excision After Favorable Response to Preoperative Chemoradiotherapy in “Early” Clinical T3 Rectal Cancer: A Propensity Score Analysis.
Gated Volumetric-Modulated Arc Therapy vs. Tumor-Tracking CyberKnife Radiotherapy as Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: A Dosimetric Comparison Study Focused on the Impact of Respiratory Motion Managements.
Liver Transplantation After Transarterial Chemoembolization and Radiotherapy for Hepatocellular Carcinoma with Vascular Invasion.
Preoperative chemoradiotherapy followed by local excision in clinical T2N0 rectal cancer.
Prevalence and clinical significance of cellular and acellular mucin in patients with locally advanced mucinous rectal cancer who underwent preoperative chemoradiotherapy followed by radical surgery.
Protective effect of ��-lipoic acid against radiation-induced fibrosis in mice.
Alpha-fetoprotein normalization as a prognostic surrogate in small hepatocellular carcinoma after stereotactic body radiotherapy: a propensity score matching analysis.
Effectiveness of adjuvant radiotherapy after local excision of rectal cancer with deep submucosal invasion: a single-hospital, case-control analysis
Influence of Preoperative Chemoradiotherapy on the Surgical Strategy According to the Clinical T Stage of Patients With Rectal Cancer.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Contact With Us
×
Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) Cancer treatment abroad?
2) CAR T-Cell therapy
3) Cancer vaccine
4) Online video consultation
5) Proton therapy